N-(Piperidin-4-yl)benzenesulfonamide, 95.0%, 500mg

5-Ethynyl-UTP, ≥95%, 10 µl, plastic packaging.

tert-Butyl 2',6'-dichloro-5,6-dihydro-[4,4'-bipyridine]-1(2H)-carboxylate, 97.0%, 250mg

tert-Butyl (3S,4R)-3-(hydroxymethyl)-4-(4-methoxyphenyl)pyrrolidine-1-carboxylate, 95.0%, 250mg

Methyl 7-methoxy-1H-indole-2-carboxylate, 98%, 100mg

Methyl 2-oxo-1,2-dihydropyrimidine-5-carboxylate hydrobromide, 95.0%, 250mg

Cyclobutyl 2-(4-fluorophenyl)ethyl ketone, 97.0%, 1g

Ethyl 3-Oxo-3-(4-chlorophenyl)propionate>98.0%(GC)1g

1,3-Difluoro-5-propylbenzene>98.0%(GC)1g

ETHYL 3-(6-FLUOROPYRIDIN-3-YL)PROPANOATE, 95.0%, 250mg

4,4'-Biphenyldiboronic Acid>95.0%(T)5g

1,1-Dimethoxycyclohexane>96.0%(GC)25mL

(S)-2-Phenylmorpholine, 95.0%, 10g